Supplemental Table 1. Kaplan-Meier analyses to estimate median time to toxicity by lactate dehydrogenase levels and stage at diagnosis.

Supplemental data table for publication titled "Association between baseline lactate dehydrogenase and immune-related adverse events among patients with melanoma varies by tumor stage at immune checkpoint inhibitor initiation". The table illustrates the time to any organ system toxicity development by level of lactate dehydrogenase (elevated levels defined as 210 U/L by institutional standards), stratified by stage of melanoma tumor at time of immune checkpoint inhibitor therapy initiation.本数据集为发表于题为《基线乳酸脱氢酶（lactate dehydrogenase）与黑色素瘤患者免疫相关不良事件（immune-related adverse events）的关联随免疫检查点抑制剂（immune checkpoint inhibitor）启动时的肿瘤分期而异》的学术论文的补充数据表。该数据表展示了按乳酸脱氢酶水平（机构标准将升高阈值定义为210 U/L）分层的任一器官系统毒性的发生时间，分层依据为免疫检查点抑制剂治疗启动时的黑色素瘤肿瘤分期。